Etofylline

乙羟茶碱

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEtofylline
Drug Alias Name乙羟茶硷etofyllinumetofilinaOxyphyllin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator activated receptor agonists
TargetsPeroxisome proliferator activated receptor
Therapy Area/IndicationsCardiovascular DiseasesRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsCardiovascular DiseasesRespiratory Tract Diseases
Inactive IndicationsN/A

Other Information

ATC CodeC04AD04
Related LinksKEGG